Spherix Global Insights

June 24, 2021

As GSK, Aurinia Heat up the Lupus Nephritis Category, Analyst Gauges Doctors’ First Impressions

From: FiercePharma

By: Beth Snyder Bulik

Home

 

The lupus nephritis category is sporting a first-ever brand battle—two new-to-category drugs with very different profiles and marketing strategies…(read more).